IMPAKT: Improving Indigenous patients' access to kidney transplantation.

Funded Activity Summary

Indigenous Australians develop end-stage renal disease (ESRD) at up to thirty times the rate for non-Indigenous Australians. Almost a half of Indigenous ESRD patients come from remote regions without ESRD treatment services. People with end-stage renal disease (ESRD) need dialysis or a transplant to stay alive. Most patients from remote communities need to relocate to regional centres to receive haemodialysis. This causes profound isolation, significant community disruption and worsens survival. Transplantation is the best treatment for most people with ESRD. Compared with long-term dialysis, it is associated with a better quality of life, a longer life expectancy, and lower costs to the health-care system. Indigenous Australians are over-represented in the ESRD population, but have a significantly lower chance of receiving a transplant than non-indigenous Australians. In this research, the IMPAKT study, we aim to identify Indigenous Australians' barriers to access to renal transplantation for treatment of their ESRD, and to propose strategies to reduce disparities in Indigenous Australians' access to renal transplantation. The nephrologists who regulate access to renal transplantation in Australia are members of the research team. This should facilitate the translation of research findings into improved access to renal transplantation for Indigenous patients.

Funded Activity Details

Start Date: 01-01-2003

End Date: 01-01-2005

Funding Scheme: NHMRC Project Grants

Funding Amount: $444,725.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Indigenous Health

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Aboriginal | Health Inequalitites | Indigenous Health | Kidney Transplantation | Renal Failure | Service Delivery | Transplantation

Related Links